Clinical Trial Update: A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy [Phase 4]

View source ↗

Summary

A national multicentre Phase 4 trial evaluated the efficacy of a fixed-dose combination of valsartan and amlodipine in patients with primary hypertension not co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Valsartan/amlodipine fixed-dose combination (Valsartan/amlodipine)

Snippet

Sponsor: Novartis | Conditions: Primary Hypertension | Phase 4 | Status: COMPLETED